The focus on increasing the possibilities related to monetizing / licensing of its patents is evident in recent changes in the management. Another area of focus is the cost rationalization. That could be the reason why CFO has been promoted as the President and the CEO's chair has been eliminated. An Executive Committee will now be collectively responsible and the board has been strengthened by addition of members with expertise in the licensing business. While all this is great, the impact of this may take a little time to translate into numbers. It also remains to be seen how soon the Ericsson deal will start to have a major impact on the company's financials. The results of the last quarter were nothing special and the CEO had still marked it as a transformational quarter. He had highlighted the focus of the company on licensing revenues and the Ericsson deal was specifically highlighted. Since the company does own technologies with huge monetizing potential, proper management / handling of the affairs will definitely help scale up the efforts. The company's strategy of focusing on licensing for optimizing the value of its patents related to 2G / 3G and 4G technologies and cloud based mobile apps & services does hold a lot of potential in today's markets. Even small companies like PLC Systems (PLCSF) which is a small medical devices company, are attempting to leverage the value of single technologies which they own. PLC Systems owns several patents related to its only product RenalGuard. The Unwired stock, meanwhile, remains weak and seems to be heading towards recent lows. Some real impact on the balance sheet is required quickly to change the fortunes for the stock. In absence of that the stock may continue to remain subdued. The investors are hoping that the promises related to improvement in fundamentals are fulfilled soon.
